SC
Sadhana Chakroborty
About Sadhana Chakroborty
Data last updated:
Sadhana Chakroborty is a Director at Inkas Pharmaceuticals Private Limited (since 2022). The company operates in Food And Beverages. Inkas Pharmaceuticals Private Limited reported revenue of ₹9.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Inkas Pharmaceuticals Private Limited U24303AS2022PTC022460 | Director | 19 Jan 2022 | 2022 | ₹9.7 Lakh (FY 2025) | Active |
Board colleagues of Sadhana Chakroborty
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satyabrata Goswami | 09473348 | Inkas Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sadhana Chakroborty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sadhana Chakroborty
Sadhana Chakroborty currently holds 1 directorship: Inkas Pharmaceuticals Private Limited (Director, since 19 Jan 2022, revenue ₹9.7 Lakh (FY 2025)).
Sadhana Chakroborty was first appointed on 19 Jan 2022 as Director at Inkas Pharmaceuticals Private Limited.
The current boards of Sadhana Chakroborty's companies include Satyabrata Goswami (Inkas Pharmaceuticals Private Limited).